Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications

Published:2012-05-01 Issue:20 Volume:18 Page:2981-2994
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Priego Eva-Maria,Karlsson Anna,Gago Federico,Camarasa Maria-Jose,Balzarini Jan,Perez-Perez Maria-Jesus

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NiFe2O4/poly(ethylene glycol)/lipid–polymer hybrid nanoparticles for anti-cancer drug delivery;New Journal of Chemistry;2020

2. Revitalizing the AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Cell Line;Frontiers in Oncology;2018-11-14

3. Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism;Cancers;2018-07-23

4. Molecular signature pathway of gene protein interaction in human mitochondrial DNA (mtDNA) metabolism linked disease;Indian Journal of Medical Specialities;2018-04

5. Syntheses of C-6 Aryl- and Alkynyl-Substituted Thymidines from Thymidinetrans-5,6-Bromohydrins;European Journal of Organic Chemistry;2017-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP